Marshall Wace
EVO icon

Marshall Wace’s Evotec EVO Stock Holding History

Marshall Wace’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38K Buy
15,189
+2,266
+18% +$7.3K ﹤0.01% 3003
2025
Q4 		$39.8K Buy
+12,923
New +$44.3K ﹤0.01% 2792
2025
Q3 		– Sell
-40,310
Closed -$169K – 3013
2025
Q2 		$169K Buy
+40,310
New +$158K ﹤0.01% 2481
2022
Q1 		– Sell
-16,272
Closed -$387K – 3524
2021
Q4 		$387K Buy
+16,272
New +$379K ﹤0.01% 2932

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace's EVO Position: Q1 2026 in Review

Marshall Wace increased its Evotec (EVO) stake by 18% in Q1 2026, buying an estimated $7.3K and bringing the position to 15,189 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Marshall Wace first reported a position in EVO in Q4 2021 and has held it in 4 quarters since. The position peaked at $387K in Q4 2021. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • Marshall Wace held 15,189 shares of Evotec worth $38K as of Q1 2026.
  • Marshall Wace bought 2,266 Evotec shares in Q1 2026, an estimated $7.3K.
  • Evotec made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #3003 holding.
  • Marshall Wace first reported a position in Evotec in Q4 2021 and has held it in 4 quarters since.
  • Marshall Wace's Evotec position peaked at $387K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.